Investmentsolidgrowthindia

QMSMEDIIIIIIIIII.....》》》》》 ♐♐ 175+++ Wow

#zyduslife -» charts —» single move big way..on the card ( positive news Multiple ) - charts showing multipal breakout - 12 3 45 pattern on the card for big move i have own sl

USE TRALLING SSL FOR MORE GAINSSS WATCH IT ZYDUSLIFE.......》》》》》》》》》 1165+++++++++++🫵🏻🫵🏻🫵🏻🫶🏻🫶🏻🫶🏻🫶🏻🫶🏻🫶🏻🫶🏻🫵🏻🫵🏻💹💹💹💹♐♐♐♐♐♐♐♐♐♐♐♐♐ IF HOLD ABOVE OUR POINT THEN BOOM BOOM BOOM 💥 💥 💥 💥 💥 💥 💥

*🌟 Clinical & Commercial Breakthroughs* *ALS Treatment Boost:* Brokerage firm Bernstein issued an *Outperform call with a target price of ₹1,457 per share*. This optimism follows Novartis' decision to discontinue its rival drug (VHB937) for Amyotrophic Lateral Sclerosis (ALS), significantly improving the commercial potential for Zydus' own drug, *Usnoflast.* Usnoflast is showing clinically meaningful slowing of disease progression in its ongoing UNITE-ALS studies *Positive Trial Results for MASH:* Zydus announced highly positive topline results from its completed EVIDENCES-X *Phase II(b) clinical trial of Saroglitazar Mg* for treating Metabolic Dysfunction-Associated Steatohepatitis (MASH) *USFDA Approval Exclusivity:* The company secured final approval from the USFDA for its *Ascorbic Acid Injection,* clinching a competitive *180-day Competitive Generic Therapy (CGT) exclusivity* window *New COPD Treatment Launch:* Zydus expanded its respiratory presence by launching *REVAHALE (revefenacin)* in India. It is a once-daily nebul 🔍 Key Valuation Drivers *Pipeline Upgrades:* The massive target adjustment by Bernstein to *₹1,457* comes directly after competitive dropouts in the ALS space, lifting long-term margin profiles *Exclusivity Upside:* The 180-day competitive generic window secured for their new USFDA generic approvals gives short-term revenue stability.

ZYDUSLIFE... CONTINUE TRADEING ABOVE OUR LEVELS 1136 & TODAYS LAST POINT WAS 1141 ( TODAYS HIGH WAS 1139.90 ) I AM HOLDING LONG WITH ( HEDGE 1080-PE ) I AM HOPING BIG RALLY SINGAL DAY ( SHORT COVERING + FRESH BUYERS BY *FII & DII* BIG NEWS IN SYSTEMS ) GAP UP ALSO POSSIBAL ANY DAY I MAY WRONG THAT WHY HOLDING PUT ALSO

*TMPV* - 》》 320+ FROM 302.40..... TODAY 17_SEPT MORNING UPDATED

*TMPV* 》》》》》 320+++++++++++ 🫵🏻🫵🏻🫵🏻🫵🏻🫵🏻🫵🏻♐♐♐♐♐♐♐ BOOM 💥 💥 💥 💥 💥 💥 💥 💥 💥 💥 💥 FATAAAA

*TMPV* 》》》》》 318+++++++++++ 🫵🏻🫵🏻🫵🏻🫵🏻🫵🏻🫵🏻♐♐♐♐♐♐♐ BOOM 💥 💥 💥 💥 💥 💥 💥 💥 💥 💥 💥 FATAAAA

*TMPV* 》》》》》 315+++++++++++ 🫵🏻🫵🏻🫵🏻🫵🏻🫵🏻🫵🏻♐♐♐♐♐♐♐ BOOM 💥 💥 💥 💥 💥 💥 💥 💥 💥 💥 💥 FATAAAA

*TMPV* 》》》》》 313+++++++++++ 🫵🏻🫵🏻🫵🏻🫵🏻🫵🏻🫵🏻♐♐♐♐♐♐♐

*TMPV* 》》》》》 310++++++++ 🫵🏻🫵🏻🫵🏻🫵🏻🫵🏻🫵🏻♐♐♐♐♐♐♐

*TMPV* 》》》》》 309++++++++

#CNX_IT_NIFTY - » STOCKS SUDDENLY STARTED

*Brent Crude Oil 🛢* Sinking 📉🫵🏻📉🫵🏻📉🫵🏻📉🫵🏻📉🫵🏻📉🫵🏻📉🫵🏻📉 Once again near 104$++ crashing

*BHEL* - 5 time exsersize exsersize Happen 405_413 To 428_437 Channels showing. Consolidation This happening last may onwards May be This time weekly & Daily Charts RSI combination Breakout going To happen look like Let see I am watching very closely ( Resently told u all ) Picture abhi baki hai mere dost 🫶🏻®️🪬🪬🪬🪬

ZYDUSLIFE.......》》》》》》》》》 1139++++++++++🫵🏻🫵🏻🫵🏻🫶🏻🫶🏻🫶🏻🫶🏻🫶🏻🫶🏻🫶🏻🫵🏻🫵🏻💹💹💹💹♐♐♐♐♐♐♐♐♐♐♐♐♐ IF HOLD ABOVE OUR POINT THEN BOOM BOOM BOOM 💥 💥 💥 💥 💥 💥 💥

There is no doubt that india is at its growth stage, but I think the most lucrative opporunities in india will be in aerospace and space industry. For Aerospace, the signals are clear: • The component exports reached $7 bn in FY25 a 5x jump from FY20 levels. • As we are observing growing number of airports with Indian airlines making order of 1,700+ aircrafts. • The global industry has a 17,000-aircraft backlog. • Airbus, Boeing and Safran are expanding their sourcing from India, currently at $1.4-1.6bn. • India’s MRO market could nearly double over the next five years. And India has the right ingredients for it Engineering talent, lower manufacturing costs, policy support and a growing base of globally certified suppliers. I am not talking about building aircraft yet, but about the picks and shovels Engine components, precision manufacturing, specialized tooling, certified subassemblies and MRO. The obstacle here is customer approvals which takes years, but once a supplier enters a global aircraft pro